A Hexa-rhodium Metallopeptide Catalyst for Site-Specific Functionalization of Natural Antibodies
Authors:
- 29 August 2017
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 139 (36) , 12617-12622
Abstract
Preparation of antibody–drug conjugates (ADCs), an emerging novel class of highly targeted biological hybrid agents, necessitates precise control of conjugation reactivity. Antibodies have complex multistranded architectures, and specific modification of natural antibodies has proven quite challenging. Here, we demonstrate that cooperative activity of a multimetallic metallopeptide enables efficient site-specific antibody functionalization, based on molecular recognition of the constant Fc region. This interplay of multiple metal centers enables introduction of an orthogonal alkyne handle into monoclonal or polyclonal antibodies from different species in an Fc-specific fashion. Elaboration of this simple functionalization allows preparation of conjugates with fluorophore, affinity handle, and pharmacological agents. This method opens a new opportunity for quick and easy production of well-defined antibody conjugates from a variety of antibody sequence and species of origin.Keywords
Funding Information
- National Science Foundation (CHE-1055569, CHE-1609654)
- Welch Foundation (C-1680)
This publication has 41 references indexed in Scilit:
- Antibody-drug conjugates—an emerging class of cancer treatmentBritish Journal of Cancer, 2016
- Locked by Design: A Conformationally Constrained Transglutaminase Tag Enables Efficient Site‐Specific ConjugationAngewandte Chemie International Edition, 2015
- Antibody–Drug Conjugates: An Emerging Concept in Cancer TherapyAngewandte Chemie International Edition, 2014
- Production of Site-Specific Antibody–Drug Conjugates Using Optimized Non-Natural Amino Acids in a Cell-Free Expression SystemBioconjugate Chemistry, 2014
- Site-specific antibody drug conjugates for cancer therapymAbs, 2013
- Synthesis of site-specific antibody-drug conjugates using unnatural amino acidsProceedings of the National Academy of Sciences, 2012
- Antibody-Radionuclide Conjugates for Cancer Therapy: Historical Considerations and New TrendsClinical Cancer Research, 2011
- Molecularly Defined Antibody Conjugation through a Selenocysteine InterfaceBiochemistry, 2009
- Antibody−Drug Conjugates: Linking Cytotoxic Payloads to Monoclonal AntibodiesBioconjugate Chemistry, 2009
- Directional conjugation of antibodies to nanoparticles for synthesis of multiplexed optical contrast agents with both delivery and targeting moietiesNature Protocols, 2008